Keep Your Portfolio Out of the Operating Room

I once had one of the worst stomach aches. My doctor surprised me, saying that we should do nothing to treat it. Time proved him right. My doctor's minimalist approach applies to a lot in life, especially to investing today... [Stansberry Research Logo] Delivering World-Class Financial Research Since 1999 [DailyWealth] Keep Your Portfolio Out of the Operating Room By Sean Michael Cummings, analyst, True Wealth --------------------------------------------------------------- I was prone to stomachaches in college, so I often shrugged them off... But on an otherwise normal day, I had some of the worst gut pain I'd ever experienced... so I headed for the hospital to get checked out. Everything about my visit was routine. A nurse took my pulse, then my doctor gave me a standard exam. Then he said something that completely took me by surprise... that we should do nothing for my stomach pain. I was taken aback. Were my symptoms not severe enough to warrant some sort of treatment? I pressed my doctor for more information, so he detailed an alternative, more aggressive plan. I could get a scope – an invasive procedure... and there was a chance something could go seriously wrong. That's when he added one of the most memorable insights I've ever heard, in medicine or anywhere else... "Sean, I may be a doctor. But I'm also a minimalist." Time proved him right – the stomachache subsided in a few days. And that lesson stuck with me. My doctor's minimalist approach applies to a lot in life... and especially to investing today. Market volatility is rampant, and the pain is very real. It may feel like the only option is to sell right now before things get worse. But instead of getting aggressive with your portfolio... it may be time to do nothing. Let me explain... --------------------------------------------------------------- Recommended Links: [$3,000 Gold Coming Soon?]( Gold could be on the verge of the biggest bull run in half a century. (It gained 1,700% during the high-inflation 1970s.) And legendary analyst Dan Ferris believes you MUST own shares of one extraordinary gold stock. He says it's likely better than any miner, explorer, or exchange-traded fund on Earth. It's the crown jewel of his complete plan for this dangerous market, with 1,500% potential. [Details here](. --------------------------------------------------------------- [Buy This Oil Stock BEFORE Russia's Next Move]( Stocks are plummeting after Russia's invasion of Ukraine. The shutdown of a major energy pipeline to Russia could create a historic shock in oil prices and send oil stocks soaring. But do NOT buy Chevron or ExxonMobil. Instead, this small Texas oil stock could make you 100%-plus if you get in immediately, before the oil crisis escalates. [Click here for the full details](. --------------------------------------------------------------- Last Monday, JPMorgan Chase issued an eyebrow-raising warning to investors. It cautioned that selling stocks right now carries too much risk. While this may sound like the opposite of what you'd expect, there's sound reasoning behind it... One way we can unpack JPMorgan's message is by observing the CBOE Volatility Index ("VIX"). This indicator measures fear by looking at expected volatility over the next 30 days. When the VIX is low, it means traders expect the market to chug along with no surprises... But a rising VIX means investors are fearful of big swings ahead in stocks. Since 1990, this index has had a median of 17.6. But today's reading is 33.3... the highest we've seen since the beginning of 2021. This may seem like a flashing signal to head for the exits. But it's not that simple... In March 2003, a five-year bull market started. The VIX was at 33.6. And at the bottom of the housing crisis in 2009, the VIX was at 50.2. The VIX peaked at 82.7 during the COVID-19 drawdown. And the bottom was only eight days later. All this inconsistency is because the VIX is a backward-looking measure. If you could predict spikes in it and sell before they happen, you could beat the market... But the thing is, the VIX shows uncertainty that traders have already factored in. A heightened VIX is not a reliable sell signal. In fact, it often indicates a market bottom – the environment in which you want to buy stocks. Now, I'm not advocating buying stocks today. But if you sell due to the current market mood, you will be acting on sentiment. And when you want to get back in, you will have to act on sentiment a second time... So the odds of something going wrong are twice as high... Or as JPMorgan warned last week, selling stocks right now is too risky. Still, if you're feeling uneasy about today's uncertain market, I do have some suggestions for you... Stick to your investing plan and keep your time horizon long. If you do those things, then you won't need to act on any short-term shake-ups. You'll be in control, reducing your margin of error. I know the world is uncertain, and that investor pain is excruciating right now. It's an extremely tempting time to doctor your portfolio... But I urge you to embrace your inner minimalist instead. Now is a great time to do nothing. Good investing, Sean Michael Cummings Further Reading "When times get tough, our intuition tells us to do more," Steve writes. But as an investor, doing more can be one of the worst things for your portfolio... Get the full story here: [Now Is Not the Time to Tinker With Your Investment Strategy](. "The market has a certain feel to it," Matt Weinschenk says. Investors are always driven by fear and greed. And when you're looking for what's coming next, that's usually more important than any number or chart... [Learn more here](. INSIDE TODAY'S DailyWealth Premium This kind of pessimism will blow up your portfolio... It's a volatile time for the U.S. economy, and that has many folks scared of stocks. But these pessimists are making a fundamental mistake that could cost them dearly... [Click here to get immediate access](. Market Notes HIGHS AND LOWS NEW HIGHS OF NOTE LAST WEEK AbbVie (ABBV)... [pharmaceuticals]( Palo Alto Networks (PANW)... [cybersecurity]( Travelers (TRV)... [insurance]( Lockheed Martin (LMT)... ["offense" contractor]( Raytheon Technologies (RTX)... ["offense" contractor]( Northrop Grumman (NOC)... "offense" contractor Viper Energy Partners (VNOM)... oil and gas Cheniere Energy (LNG)... natural gas Mosaic (MOS)... [fertilizer]( Nutrien (NTR)... [fertilizer]( Steel Dynamics (STLD)... [steel]( Altria (MO)... cigarettes Hershey (HSY)... ["Global Elite" chocolatier]( NEW LOWS OF NOTE LAST WEEK JPMorgan Chase (JPM)... financial giant Citigroup (C)... financial services MasTec (MTZ)... 5G infrastructure Alibaba (BABA)... Chinese e-commerce platform Match (MTCH)... online dating BorgWarner (BWA)... auto parts Manchester United (MANU)... soccer --------------------------------------------------------------- [Tell us what you think of this content]( [We value our subscribers’ feedback. To help us improve your experience, we’d like to ask you a couple brief questions.]( [Click here to rate this e-mail]( You have received this e-mail as part of your subscription to DailyWealth. If you no longer want to receive e-mails from DailyWealth [click here](. Published by Stansberry Research. You’re receiving this e-mail at {EMAIL}. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberrycustomerservice.com. Please note: The law prohibits us from giving personalized investment advice. © 2022 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 or [www.stansberryresearch.com](. Any brokers mentioned constitute a partial list of available brokers and is for your information only. Stansberry Research does not recommend or endorse any brokers, dealers, or investment advisors. Stansberry Research forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Stansberry Research (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.